期刊
AMERICAN JOURNAL OF MEDICINE
卷 122, 期 11, 页码 977-991出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2009.02.013
关键词
Acute asthma; Adults; Asthma; Asthma exacerbation; Corticosteroids; Emergency department; Hospital; Review; Treatment
资金
- Parker B. Francis Fellowship Award
- National Institutes of Health [HL67850]
- National Health and Medical Research Council (NHMRC)
- NHMRC
- Government of Canada (BHR)
The objective of this umbrella review is to synthesize the evidence and provide clinicians a single report that summarizes the state of knowledge regarding the use of corticosteroids in adults with acute asthma. Systematic reviews in the Cochrane Library and additional clinical trials published in English from 1966 to 2007 in MEDLINE, EMBASE, CINAHL, and Cochrane CENTRAL, and references from bibliographies of pertinent articles were reviewed. Results indicate that the evidence base is frequently limited to small, single-center studies. Findings suggest that therapy with systemic corticosteroids accelerates the resolution of acute asthma and reduces the risk of relapse. There is no evidence that corticosteroid doses greater than standard doses (prednisone 50-100 mg equivalent) are beneficial. Oral and intravenous corticosteroids, as well as intramuscular and oral corticosteroid regimens, seem to be similarly effective. A nontapered 5- to 10-day course of corticosteroid therapy seems to be sufficient for most discharged patients. Combinations of oral and inhaled corticosteroids on emergency department/hospital discharge might minimize the risk of relapse. c 2009 Elsevier Inc. All rights reserved. (C) The American Journal of Medicine (2009) 122, 977-991
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据